ListarArtículos, capítulos, libros...UCO por tema "Urothelial carcinoma"
Mostrando ítems 1-4 de 4
-
Alternative splicing in bladder cancer: potential strategies for cancer diagnosis, prognosis, and treatment
(Wiley, 2023)Bladder cancer is the most common malignancy of the urinary tract worldwide.The therapeutic options to tackle this disease comprise surgery, intravesical orsystemic chemotherapy, and immunotherapy. Unfortunately, a wide ... -
Current Strategies and Novel Therapeutic Approaches for Metastatic Urothelial Carcinoma
(MDPI, 2020)Urothelial carcinoma (UC) is a frequent cause of cancer-related deaths worldwide. Metastatic UC has been historically associated with poor prognosis, with a median overall survival of approximately 15 months and a 5-year ... -
Immune Checkpoint Inhibitors in Urothelial Carcinoma: Recommendations for Practical Approaches to PD-L1 and Other Potential Predictive Biomarker Testing
(MDPI, 2021)Immuno-oncology (IO) agents (anti–programmed cell death 1 (PD-1) and anti–programmed cell death-ligand 1 (PD-L1)) are approved as first- and second-line treatments for metastatic UC. PD-L1 expression levels in UC tumors ... -
Immunohistochemical analysis of chromatin remodeler DAXX in high grade urothelial carcinoma
(BioMed Central, 2013)Background/Aims: The chromatin remodeler DAXX, a predominantly nuclear protein, regulates the status of chromatin organization. The aim of this exploratory immunohistochemical study was to evaluate DAXX protein expression ...